Navigation Links
FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments
Date:12/30/2011

BEDMINSTER, N.J., Dec. 30, 2011 /PRNewswire/ -- ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), and an international specialty pharmaceutical company, today announces that the U.S. Food and Drug Administration (FDA) has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS (Risk Evaluation and Mitigation Strategy) Access program. This new REMS is a single shared system for all TIRF products, including ABSTRAL® (fentanyl) sublingual tablets, an opioid analgesic used in the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

The goals of the TIRF REMS Access program are to mitigate the risk of misuse, abuse, addiction, overdose and serious complications due to medication errors by:

  • Prescribing and dispensing TIRF medicines only to appropriate patients, which includes use only in opioid-tolerant patients.
  • Preventing inappropriate conversion between fentanyl products.
  • Preventing accidental exposure to children and others for whom it was not prescribed.
  • Educating prescribers, pharmacists and patients on the potential for misuse, abuse, addiction and overdose of TIRF medicines.

TIRF products are available only through REMS programs, which require enrollment by prescribers, their patients, pharmacies and distributors. Today, TIRF manufacturers have separate REMS programs and a health care provider and pharmacy must enroll in multiple REMS programs, corresponding to the TIRF product they choose to prescribe or dispense.  The new shared REMS – modeled after the program created for ABSTRAL - will go live in March 2012; at that time, prescribers, pharmacies, patients, and distributors may all be enrolled in a single program for these products. All stakeholders currently enrolled
'/>"/>

SOURCE ProStrakan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... MOC-etomidate detected no sudden drops in blood pressure , ... of a common general anesthesia has been developed that may ... rats put under with MOC-etomidate, a chemically altered version of ... blood pressure to drop suddenly or slow adrenal gland activity, ...
... efforts, but a nasal spray version might help , THURSDAY, ... of doses of injectable swine flu vaccine U.S. officials now ... coming in the form of a nasal spray. , Since ... doses spread a month apart, the amount of vaccine will ...
... , , Potential Size of ... Texas Medicaid Program; Seniors, Care at Risk, Local ... Texas, July 23 /PRNewswire-USNewswire/ -- Expressing growing concern ... as part of ongoing health reform negotiations could have a disastrous impact ...
... , TUCSON, Ariz., July 23 ... today announced that it is scheduled to report financial results for its ... the market closes. , , Providence will ... 8:00 a.m. Arizona and PDT) Tuesday, August 11, 2009, to discuss its ...
... remaining life in wheelchair, nursing facilities after nurse failed to alert physician ... KENT, Wash., July 23 A King County Superior Court ... million yesterday for a medical center,s failure to alert her physician of ... , The jury concluded the actions of Renton, ...
... jolly, good year for Dr. Bhimu Patil. The director ... been named a fellow by three professional entities for his ... title of "fellow" is bestowed by scientific societies to designate ... Patil was first honored in January 2009 as fellow ...
Cached Medicine News:Health News:New Anesthesia May Be Safer for Critically Ill 2Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 2Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 3Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 4Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 5Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 6Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 7Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 8Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 9Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 10Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 11Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 12Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 13Health News:U.S. Expects 160 Million Doses of Swine Flu Vaccine by October 14Health News:Expressing Growing Concern, THCA Urges Texas Congressional Delegation to Protect Seniors' Medicare-Funded Nursing Home Care as Health Reform Debate Proceeds 2Health News:Providence Service Corporation to Report Second Quarter 2009 Results on Monday, August 10th After the Market Closes 2Health News:Providence Service Corporation to Report Second Quarter 2009 Results on Monday, August 10th After the Market Closes 3Health News:Jury Awards Valley Medical Center Patient $1.8 Million for Nursing Negligence 2Health News:Jury Awards Valley Medical Center Patient $1.8 Million for Nursing Negligence 3Health News:Patil: For he's a jolly good science fellow 2
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
This unit is the finest standalone handswitch bipolar unit available....
...
...
Medicine Products: